Aromasin Side Effects, Adverse Risks, and Health Benefits

Aromasin Side Effects: Bone Loss and Fractures. The breast-cancer drug Aromasin, used in trials to prevent the cancer from developing in postmenopausal women, worsened bone loss in these women and raised their risk for fractures, a new study finds. The study was published in the Feb. 6 online edition of The Lancet Oncology.

Pfizer Inc, the world’s biggest drug maker, manufactures the drug.

Read More

Gleevec Side Effects and Health Precautions

Gleevec Side Effects. Gleevec, the drug commonly used to treat tumors of the stomach and digestive system, has been approved by United States regulators for expanded use in patients with a rare gastrointestinal cancer — and trials used to gain approval showed that the drug significantly prolonged the lives of patients.

On Jan. 31, the U.S. Food and Drug Administration granted regular approval to Gleevec (imatinib) for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST).

Read More